
Thymosin Alpha-1
£38
In stock, ships today
Third-party lab report
Batch LLX5.221 99% purity Tested 8 Jun 2026
LL-37 is a 37-amino acid cationic antimicrobial peptide (AMP) derived from the C-terminal end of the human cathelicidin antimicrobial protein (hCAP-18). As an endogenous component of innate immune research, it is investigated in preclinical models for its roles in microbial membrane research, immune cell signalling, and inflammatory pathway studies.
Research into LL-37 examines its direct interaction with microbial membrane systems and the modulation of innate immune signalling pathways. In experimental systems, it is investigated for its association with bacterial membrane integrity research through its amphipathic alpha-helical structure. It is also studied for its interaction with Formyl Peptide Receptor 2 (FPR2) and other pattern recognition receptor signalling cascades.
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.